336570.KQ
WON TECH Co.,Ltd.
KOE · Healthcare · Medical - Specialties · KR
KRW 4,860.00
+0.21%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 167.4B | 156.8B | 115.3B | 115.6B | 81.5B |
| Cost of Revenue | 50.0B | 47.6B | 41.1B | 41.4B | 32.7B |
| Gross Profit | 117.3B | 109.3B | 74.1B | 74.3B | 48.8B |
| Operating Expenses | |||||
| R&D Expense | 5.7B | 7.8B | 1.7B | 967.6M | 661.4M |
| SG&A Expense | 49.3B | 33.5B | 22.6B | 16.0B | 19.8B |
| General & Admin Expense | 3.8B | 3.5B | 2.9B | 1.7B | 2.7B |
| Selling & Marketing Expense | 28.5B | 30.1B | 19.7B | 14.3B | 10.7B |
| Other Expenses | 20.8B | 16.2B | 15.0B | 11.2B | 1.6B |
| Total Operating Expenses | 75.2B | 57.6B | 39.4B | 28.2B | 22.1B |
| Cost and Expenses | 125.2B | 105.2B | 80.5B | 69.6B | 54.8B |
| Operating Income (EBIT) | 42.2B | 51.7B | 34.8B | 46.0B | 26.8B |
| Non-Operating | |||||
| Interest Income | 2.5B | 2.4B | 2.4B | 1.6B | 250.9M |
| Interest Expense | 2.8B | 2.4B | 2.3B | 684.6M | 385.2M |
| Net Interest Income | (296.8M) | (49.9M) | 83.5M | 927.9M | (134.3M) |
| Other Non-Op Income/Expense | 14.9B | (5.5B) | 3.8B | 1.7B | (9.0B) |
| Non-Operating Income (excl Interest) | (1.1B) | 3.1B | (6.1B) | (2.4B) | 8.6B |
| EBT (Pre-Tax Income) | 57.1B | 46.2B | 38.6B | 47.8B | 17.8B |
| Income Tax Expense | 17.1B | 10.9B | 9.5B | 9.0B | 4.4B |
| Bottom Line | |||||
| Net Income | 40.0B | 35.2B | 29.1B | 38.8B | 13.4B |
| Earnings from Cont. Ops | 40.0B | 35.2B | 29.1B | 38.8B | 13.4B |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 40.0B | 35.2B | 29.1B | 38.8B | 13.4B |
| Per Share | |||||
| Basic EPS | ₩449 | ₩393 | ₩327 | ₩441 | ₩158 |
| Diluted EPS | ₩444 | ₩393 | ₩327 | ₩441 | ₩158 |
| Revenue Per Share | ₩1,897 | ₩1,743 | ₩1,293 | ₩1,313 | ₩963 |
| Shares | |||||
| Basic Shares Outstanding | 88.2M | 90.0M | 89.1M | 88.1M | 84.6M |
| Diluted Shares Outstanding | 90.3M | 90.0M | 89.1M | 88.1M | 85.0M |
| Profitability Metrics | |||||
| EBITDA | 46.7B | 51.5B | 43.3B | 50.3B | 19.9B |
| D&A | 3.3B | 2.9B | 2.4B | 1.8B | 1.7B |
| EBIT | 43.4B | 48.6B | 40.9B | 48.5B | 18.2B |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026